Breaking News

Lonza Expands Encapsulation and HPAPI Capabilities in North America

A new suite added that facilitates encapsulation of highly potent compounds

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza has expanded its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company will install a new Harro Hӧfliger Modu-C MS encapsulation unit at its integrated product development and manufacturing facility in Tampa, FL to further strengthen its speed-to-market capabilities. The specialized drum-dosing technology is used for powder-in-capsule (PIC) filling for oral solid dosage forms including dry powder inhaler (DPI)...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters